Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia

scientific article

Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2005.12.516
P698PubMed publication ID15767647

P50authorJorge Eduardo CortesQ60320900
Hagop KantarjianQ60394812
Alessandra FerrajoliQ64026240
William G WierdaQ64026278
Stefan FaderlQ64026412
Susan O'BrienQ66370727
Francis GilesQ66380831
Guillermo Garcia-ManeroQ66385413
Michael J. KeatingQ66429598
Maher AlbitarQ66429840
Susan LernerQ66429891
Sijin WenQ88490018
P2093author name stringMiloslav Beran
Kim-Anh Do
Charles Koller
Deborah Thomas
P433issue18
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
rituximabQ412323
lymphocyteQ715347
P304page(s)4070-4078
P577publication date2005-03-14
P1433published inJournal of Clinical OncologyQ400292
P1476titleChemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
P478volume23